Quantitative Analysis of Amorphous Form in Indomethacin by Near Infrared Spectroscopy Combined with Partial Least Squares Regression Analysis

Overview

Journal Molecules

Publisher MDPI

Specialty Biology

Date 2024 Nov 27

PMID 39598679

Authors

Mingdi Liu

Rui Fu

Jichao Liu

Ping Song

Haichao Li

Weibing Dong

Zan Sun

Affiliations

Soon will be listed here.

Abstract

Indomethacin (INDO) is a synthetic non-steroidal antipyretic, analgesic, and anti-inflammatory drug that commonly exists in both amorphous and crystalline states. Its amorphous state (A-INDO) is utilized by pharmaceutical companies as an active pharmaceutical ingredient (API) in the production of INDO drugs due to its higher apparent solubility and bioavailability. The crystal state also encompasses various crystal forms such as the α-crystal form (α-INDO) and γ-crystal form (γ-INDO), with the highly crystalline and insoluble γ-INDO being commercially available. A-INDO, existing in a thermodynamically high-energy state, is susceptible to several factors during the preparation, storage, and transportation of API leading to its conversion into γ-INDO, thus impacting the bioavailability and efficacy of INDO drugs. Therefore, quantitative analysis of the A-INDO/γ-INDO content in INDO API becomes essential for controlling the production quality of INDO. The primary objective of this study is to investigate the feasibility of NIR for the quantitative analysis of A-INDO in INDO API, and to further elucidate its quantitative analysis mechanism. The NIR spectral data were collected for A-INDO and γ-INDO binary mixture samples with different resolutions, and these spectra were then selected and reconstructed using the interval partial least square (iPLS) method. Different pretreatment methods were employed to enhance the reconstructed spectra by highlighting relevant eigen information while eliminating invalid information caused by environmental factors or physical characteristics of samples. The most suitable PLSR model for quantitative analysis of A-INDO within the range of 0.0000-100.0000% /% was established, screened, and validated. From various perspectives, including distribution of spectral effective information, impact of resolution on PLSR model performance, variance contribution/cumulative variance contribution of PLSR model principal components (PCs), PC loadings, relationship between spectral scores, and A-INDO content, feasibility assessment was conducted for the quantitative analysis of A-INDO in INDO using NIR spectroscopy. Additionally, a detailed investigation on the quantitative analysis mechanism of the optimal PLSR model was undertaken including the correlation between the characteristic peaks of spectra and information regarding hydrogen groups or hydrogen bonds in A-INDO or γ-INDO molecules. This study aims to provide theoretical support for the quantitative analysis of A-INDO in INDO API as well as serve as a reliable reference method for API quantification and quality control in similar drugs.

References

Farias M, Carneiro R . Simultaneous quantification of three polymorphic forms of carbamazepine in the presence of excipients using Raman spectroscopy. Molecules. 2014; 19(9):14128-38. PMC: 6271826. DOI: 10.3390/molecules190914128. View

Chen X, Morris K, Griesser U, Byrn S, Stowell J . Reactivity differences of indomethacin solid forms with ammonia gas. J Am Chem Soc. 2002; 124(50):15012-9. DOI: 10.1021/ja017662o. View

Agatonovic-Kustrin S, Glass B, Mangan M, Smithson J . Analysing the crystal purity of mebendazole raw material and its stability in a suspension formulation. Int J Pharm. 2008; 361(1-2):245-50. DOI: 10.1016/j.ijpharm.2008.04.039. View

Qiu J, Li G, Sheng Y, Zhu M . Quantification of febuxostat polymorphs using powder X-ray diffraction technique. J Pharm Biomed Anal. 2015; 107:298-303. DOI: 10.1016/j.jpba.2015.01.005. View

da Silva V, Goncalves J, Vasconcelos F, Fernanda Pimentel M, Pereira C . Quantitative analysis of mebendazole polymorphs in pharmaceutical raw materials using near-infrared spectroscopy. J Pharm Biomed Anal. 2015; 115:587-93. DOI: 10.1016/j.jpba.2015.08.018. View

Bellur Atici E, Karliga B . Quantitative determination of two polymorphic forms of imatinib mesylate in a drug substance and tablet formulation by X-ray powder diffraction, differential scanning calorimetry and attenuated total reflectance Fourier transform infrared.... J Pharm Biomed Anal. 2015; 114:330-40. DOI: 10.1016/j.jpba.2015.06.011. View

Murdande S, Pikal M, Shanker R, Bogner R . Solubility advantage of amorphous pharmaceuticals: I. A thermodynamic analysis. J Pharm Sci. 2009; 99(3):1254-64. DOI: 10.1002/jps.21903. View

Stillinger F, Weber T . Packing structures and transitions in liquids and solids. Science. 1984; 225(4666):983-9. DOI: 10.1126/science.225.4666.983. View

Kang Y, Shao Z, Wang Q, Hu X, Yu D . Quantitation of polymorphic impurity in entecavir polymorphic mixtures using powder X-ray diffractometry and Raman spectroscopy. J Pharm Biomed Anal. 2018; 158:28-37. DOI: 10.1016/j.jpba.2018.05.026. View

10.

Liu M, Liu J, Wang Q, Song P, Li H, Sun Z . Quantitative analysis of low-content impurity crystal forms in canagliflozin tablets by NIR solid-state analysis technique. Spectrochim Acta A Mol Biomol Spectrosc. 2024; 311:124000. DOI: 10.1016/j.saa.2024.124000. View

11.

Otsuka M, Kato F, Matsuda Y . Comparative evaluation of the degree of indomethacin crystallinity by chemoinfometrical Fourier-transformed [corrected] near-infrared spectroscopy and conventional powder X-ray diffractometry. AAPS PharmSci. 2001; 2(1):E9. PMC: 2751004. DOI: 10.1208/ps020109. View

12.

Bhugra C, Pikal M . Role of thermodynamic, molecular, and kinetic factors in crystallization from the amorphous state. J Pharm Sci. 2007; 97(4):1329-49. DOI: 10.1002/jps.21138. View

13.

Kachrimanis K, Rontogianni M, Malamataris S . Simultaneous quantitative analysis of mebendazole polymorphs A-C in powder mixtures by DRIFTS spectroscopy and ANN modeling. J Pharm Biomed Anal. 2009; 51(3):512-20. DOI: 10.1016/j.jpba.2009.09.001. View

14.

Hennigan M, Ryder A . Quantitative polymorph contaminant analysis in tablets using Raman and near infra-red spectroscopies. J Pharm Biomed Anal. 2012; 72:163-71. DOI: 10.1016/j.jpba.2012.10.002. View

15.

Chadha R, Bhandari S, Arora P, Chhikara R . Characterization, quantification and stability of differently prepared amorphous forms of some oral hypoglycaemic agents. Pharm Dev Technol. 2012; 18(2):504-14. DOI: 10.3109/10837450.2012.723719. View

16.

Zappi A, Maini L, Galimberti G, Caliandro R, Melucci D . Quantifying API polymorphs in formulations using X-ray powder diffraction and multivariate standard addition method combined with net analyte signal analysis. Eur J Pharm Sci. 2019; 130:36-43. DOI: 10.1016/j.ejps.2019.01.014. View

17.

Kistenmacher T, Marsh R . Crystal and molecular structure of an antiinflammatory agent, indomethacin, 1-(p-chlorobenzoyl)-5-methoxy-2-methylindole-3-acetic acid. J Am Chem Soc. 1972; 94(4):1340-5. DOI: 10.1021/ja00759a047. View

18.

Hu Y, Erxleben A, Ryder A, McArdle P . Quantitative analysis of sulfathiazole polymorphs in ternary mixtures by attenuated total reflectance infrared, near-infrared and Raman spectroscopy. J Pharm Biomed Anal. 2010; 53(3):412-20. DOI: 10.1016/j.jpba.2010.05.002. View

19.

TAYLOR L, Zografi G . Spectroscopic characterization of interactions between PVP and indomethacin in amorphous molecular dispersions. Pharm Res. 1998; 14(12):1691-8. DOI: 10.1023/a:1012167410376. View

20.

Alonzo D, Zhang G, Zhou D, Gao Y, Taylor L . Understanding the behavior of amorphous pharmaceutical systems during dissolution. Pharm Res. 2010; 27(4):608-18. DOI: 10.1007/s11095-009-0021-1. View